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Abstract
Introduction We conducted the present study to examine the
effects of hypertonic saline solution (7.5%) on cardiovascular
function and splanchnic perfusion in experimental sepsis.
Methods Anesthetized and mechanically ventilated mongrel
dogs received an intravenous infusion of live Escherichia coli
over 30 minutes. After 30 minutes, they were randomized to
receive lactated Ringer's solution 32 ml/kg (LR; n = 7) over 30
minutes or 7.5% hypertonic saline solution 4 ml/kg (HS; n = 8)
over 5 minutes. They were observed without additional
interventions for 120 minutes. Cardiac output (CO), mean
arterial pressure (MAP), portal and renal blood flow (PBF and
RBF, respectively), gastric partial pressure of CO2 (pCO2; gas
tonometry), blood gases and lactate levels were assessed.
Results E. coli infusion promoted significant reductions in CO,
MAP, PBF and RBF (approximately 45%, 12%, 45% and 25%,
respectively) accompanied by an increase in lactate levels and
systemic and mesenteric oxygen extraction (sO2ER and
mO2ER). Widening of venous-arterial (approximately 15
mmHg), portal-arterial (approximately 18 mmHg) and gastric
mucosal-arterial (approximately 55 mmHg) pCO2 gradients
were also observed. LR and HS infusion transiently improved
systemic and regional blood flow. However, HS infusion was
associated with a significant and sustained reduction of
systemic (18 ± 2.6 versus 38 ± 5.9%) and mesenteric oxygen
extraction (18.5 ± 1.9 versus 36.5 ± 5.4%), without worsening
other perfusional markers.
Conclusion A large volume of LR or a small volume of HS
promoted similar transient hemodynamic benefits in this sepsis
model. However, a single bolus of HS did promote sustained
reduction of systemic and mesenteric oxygen extraction,
suggesting that hypertonic saline solution could be used as a
salutary intervention during fluid resuscitation in septic patients.
Introduction
Widespread microcirculatory abnormalities and cellular altera-
tions leading to an uncoupling between blood flow and meta-
bolic tissue requirements, particularly in splanchnic perfusion,
are common in septic patients and have been implicated in
sepsis-related mortality due to multiple organ dysfunction [1-
3]. While adequate oxygen supply to the gastrointestinal tract
is the key factor for maintaining physiological intestinal func-
tion, it is well known that there is a discrepancy between sys-
temic and regional variables, and that interventions that
increase systemic oxygen delivery do not necessarily result in
improved regional perfusion [4-8]. Therefore, therapeutic inter-
ventions that prevent or rapidly reduce the severity of intestinal
mucosal hypoperfusion may improve outcome in septic
patients.
Although early fluid resuscitation has been shown to improve
cardiovascular function and outcome in experimental and
human sepsis [9-11], the optimal fluid therapy is a matter of
controversy. In spite of adequate systemic hemodynamic res-
toration, hypoperfusion of the intestinal mucosa may persist
and result in deranged barrier function [4-8,12-14]. In a previ-
ous study, we found that an early, large volume of crystalloid
after live Escherichia coli injection in dogs promoted partial
D(g-a)pCO2 = difference between gastric mucosal pCO2 and arterial pCO2; D(p-a)pCO2 = difference between portal vein pCO2 and arterial pCO2; 
D(v-a)pCO2 = difference between mixed venous pCO2 and arterial pCO2; HS = hypertonic saline; LR = lactated Ringer's solution; mO2ER = 
mesenteric oxygen extraction ratio; pCO2 = partial pressure of CO2; SEM = standard error of mean; sO2ER = systemic oxygen extraction ratio.
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and transient benefits, essentially during the fluid infusion,
which were especially poor at the splanchnic bed [5].
Hypertonic saline (HS), with or without colloidal solution, has
been successfully used for treating hemorrhagic shock in ani-
mal and clinical studies [12,13,15]. Immediate plasma volume
expansion due to intracellular fluid mobilization, particularly
from erythrocytes and endothelial cells, promotes systemic
hemodynamic benefits and microcirculatory blood flow
improvement [12,13,15-18]. Moreover, in comparison with
lactated Ringer's solution (LR) resuscitation, we demonstrated
that HS resuscitation reduces bacterial translocation and lung
injury after hemorrhage [19], and avoids morphological altera-
tions in bone marrow seen after hemorrhagic shock [20]. It has
also been shown that hypertonic saline reduces neutrophil-
endothelium interactions and vascular leakage [21], and atten-
uates neutrophils' cytotoxic response post-injury [22]. Both
hemodynamic and immunomodulatory effects of hypertonic
resuscitation may provide a potential benefit for the treatment
of sepsis [15,16,18-22].
The experience with HS solutions in sepsis is limited. There-
fore, we performed the present study to test the hypothesis
that HS infusion promotes superior systemic and regional ben-
efits than conventional isotonic crystalloid infusion in experi-
mental sepsis.
Materials and methods
This study was approved by the Animal Care and Use Commit-
tee of the University of São Paulo Medical School and con-
ducted in compliance with the guidelines of the National
Regulations for the Care and Use of Laboratory Animals.
Animal preparation
Fifteen healthy male mongrel dogs weighing 14 to 20 kg each
were fasted for 12 hours before the study, with free access to
water. Anesthesia was induced with an intravenous injection of
0.1 mg/kg of morphine sulfate followed by 25 mg/kg of
sodium pentobarbital. Additional doses of pentobarbital (2
mg/kg) were used whenever required. A cuffed endotracheal
tube was placed in the trachea to allow mechanical ventilation
with a 1.0 inspired fraction of oxygen, at a tidal volume of 15
ml/kg (670 Takaoka ventilator, São Paulo, Brazil). Respiratory
rate was adjusted to maintain arterial partial pressure of CO2
(pCO2) at 40 ± 5 mmHg. A urinary bladder catheter was
placed for urinary drainage. During surgical preparation, a
heating pad was used to maintain normothermia, and the ani-
mals received LR 20 ml/kg/h to compensate for fluid losses.
Each animal received an intravenous injection of 1.5 mg/kg of
ranitidine.
The right common femoral artery was cannulated with a poly-
ethylene catheter (PE240) to measure mean arterial pressure
at the abdominal aorta and to collect arterial blood samples for
blood gas and lactate analysis. Through the right common
femoral vein, a catheter (PE240) was introduced for fluid infu-
sion.
A balloon-tipped catheter (5-Fr ARROW® Balloon Thermodi-
lution Catheter Inc., Pennsylvania, PA, USA) was inserted into
the pulmonary artery through the right external jugular vein
under guidance of pressure waves, as displayed by a mul-
tichannel monitor system. This catheter was connected to a
cardiac computer (Vigilance™, Baxter Edwards Critical Care,
Irvine, CA, USA) to measure cardiac output, using 3 ml bolus
injections of isotonic saline at 20°C. All catheters were con-
nected to disposable pressure transducers (Transpac Dispos-
able Transducer, Abbott, Chicago, IL, USA) and to a
computerized multichannel system for biological data acquisi-
tion (Acknowledge® III MP 100 WSW, Biopac Systems Inc.,
Goleta, CA, USA).
Through a midline laparotomy, an ultrasonic flow probe (Tran-
sonic Systems Inc., Ithaca, NY, USA) was placed around the
portal vein for transit time flow measurement (T206 Transonic
Volume Flowmeter, Transonic Systems). A P240 catheter was
threaded into the portal system via inferior mesenteric vein for
portal blood sampling. The abdominal cavity was then carefully
closed. After the surgical preparation was completed, the ani-
mals were allowed to recover for 30 minutes before the meas-
uring protocol was initiated and the infusion of LR was
discontinued.
A large gastric polyethylene tube was orally introduced and
placed in the stomach to allow gastric lavage and drainage
with warm isotonic saline solution until a clear fluid was
obtained. A tonometry catheter (16 F TRIP™, Datex-Ohmeda
Division, Instrumentation Corp., Helsinki, Finland) was intro-
duced orally and positioned at the large curvature of the stom-
ach. The tonometry catheter was then connected to a
calibrated gas capnometer (Tonocap, model TC-200, Tono-
metrics, Datex-Ohmeda Division) for gastric mucosal pCO2
(PgCO2) measurement every 10 minutes.
Bacterial preparation
A strain of E. coli O55, provided by the Department of Bacte-
riology of Adolfo Lutz Institute, São Paulo, Brazil, originating
from the stool of a patient with gastrointestinal sepsis, was
used in this study. In brief, according to previous studies [5,7],
the bacteria were stored in conservative milieu at room tem-
perature, activated in trypticase soy broth, plated in trypticase
soy agar and incubated at 37°C for 24 hours. Aliquots were
then suspended in sterile saline. The bacterial suspension was
estimated turbidimetrically by comparing the newly grown
bacterial suspension to known standards through spectropho-
tometry at 625 nm to obtain a culture of desired bacterial den-
sity. The same suspension was subsequently quantified by
plating successive 10-fold dilutions onto trypticase soy agar
plates and scoring visible colonies after 24 hours of incubation
at 37°C. The target dose, as calculated by the methods out-
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lined above, was 3 × 109 cells/ml or 0.6 × 1010 cfu/ml. Then,
1.2 × 1010 cfu/kg of body weight was used to induce sepsis.
Data collection and analysis
Mean systemic and pulmonary arterial pressures, heart rate,
and portal vein blood flow were continuously recorded. Car-
diac output was determined using the thermodilution tech-
nique and expressed as cardiac index, according to the
estimated body surface area. Each determination was the
arithmetic mean of three consecutive measurements when
their differences did not exceed 10%. Central venous blood
temperature was recorded from the thermistor in the pulmo-
nary artery catheter.
Blood gases, hemoglobin, hematocrit, sodium and blood lac-
tate levels were obtained from arterial, portal and mixed
venous samples at baseline (T0), then at 30, 60, 90, 120, 150,
180 and 210 minutes after the initiation of the bacterial infu-
sion. All blood samples were analyzed by a Stat Profile Ultra
Analyzer (Nova Biomedical, Waltham, MA, USA). The arterial
oxygen content (CaO2), mixed venous oxygen content (CvO2),
portal oxygen content (CpO2), systemic oxygen delivery
(sDO2), mesenteric oxygen delivery (mDO2), systemic oxygen
extraction ratio (sO2ER), mesenteric oxygen extraction ratio
(mO2ER), systemic oxygen consumption (sVO2), mesenteric
oxygen consumption (mVO2) and arteriovenous oxygen con-
tent difference (C(a-v)O2) were calculated using standard for-
mulae.
The following pCO2 gradients were calculated: D(v-a)pCO2,
as the difference between mixed venous pCO2 and arterial
pCO2; D(p-a)pCO2, as the difference between portal vein
pCO2 and arterial pCO2; D(g-a)pCO2, as the difference
between gastric mucosal pCO2, measured by gas tonometry,
and arterial pCO2.
Experimental protocol
After stabilization, baseline (T0) measurements were obtained
(Figure 1). The infusion of E. coli, in a dose of 1.2 × 1010 cfu/kg,
was initiated and maintained for 30 minutes in all groups (T30).
After 30 minutes of observation (T60), the animals were rand-
omized into two groups: fluid treatment with LR 32 ml/kg (n =
7) over 30 minutes or 7.5% HS 4 ml/kg (n = 8) over 5 minutes.
The animals were observed without additional interventions for
Figure 1
Mean arterial pressure (mmHg, mean ± standard error of the mean (SEM)), cardiac output (l/minute, mean ± SEM), portal vein blood flow (ml/minute, me n ± SEM) and renal v in blood flow (ml/minute, mean ±  during the experimental protocol
minute, mean ± SEM) and renal vein blood flow (ml/minute, mean ± SEM) during the experimental protocol. LR group received lactated Ringer's 
solution 32 ml/kg over 30 minutes, n = 7; HS group received 7.5% hypertonic saline solution 4 ml/kg over 5 minutes, n = 8. *p < 0.05 versus T0, 
both groups; †p < 0.05 versus HS; # HS, p < 0.05 versus T0. BI, bacterial infusion.
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120 minutes (T210). They were then euthanized by a pentobar-
bital overdose followed by hypertonic potassium chloride injec-
tion.
Statistical methodology
Results are presented as mean ± standard error of mean
(SEM). Statistical analysis was performed using a Statistic
Package for Social Sciences for Windows software (version
6.0, SPSS Inc., Chicago, IL, USA). Differences between
groups were analyzed using repeated measure analysis of var-
iance and post hoc Tukey's test. Linear correlation was tested
using the Spearman rank method. Statistical significance was
considered for p values less than 0.05.
Results
Effects of live E. coli infusion
Live E. coli infusion resulted in a hypodynamic sepsis state. In
spite of minor changes in mean arterial pressure and renal
blood flow, an immediate and severe impairment of cardiac
output and portal blood flow were observed (Figure 1). These
hemodynamic changes were accompanied by blood gas
changes indicative of widespread metabolic deterioration,
including progressive increases in systemic and mesenteric
oxygen extraction rates (Tables 1 and 2) with a decrease in
mixed venous and portal oxygen saturations (Figure 2), raised
arterial and portal lactate levels (Tables 1 and 2), metabolic
acidosis (Table 1), and widening of pCO2 gradients (Figure 3).
No significant changes in systemic or regional oxygen con-
sumption were detected throughout the experiment (Tables 1
and 2). Hemoglobin levels increased in both groups after bac-
terial infusion (Table 1).
Table 1
Electrolytic and systemic oxygen-derived variables in both groups
Bacterial infusion Fluid resuscitation Follow up
T0 T30 T60 T90 T120 T150 T180 T210
sDO2 (ml/minute)
LR 454 ± 44 214 ± 25a 310 ± 37a 340 ± 48a 246 ± 37a 233 ± 32a 237 ± 40a 222 ± 34a
HS 415 ± 28 274 ± 19a 350 ± 25a 308 ± 38a 279 ± 24a 292 ± 21a 298 ± 13a 290 ± 23a
sVO2 (ml/minute)
LR 95 ± 11 67 ± 9 64 ± 10 73 ± 10 60 ± 7 68 ± 7 74 ± 7 68 ± 6
HS 77 ± 11 91 ± 14 61 ± 7 52 ± 7 56 ± 6 60 ± 6 55 ± 6 58 ± 6
sO2ER (%)
LR 20 ± 2.1 31 ± 2.3a 20 ± 3.7 22 ± 3.8 30 ± 5.1 34 ± 4.7a,b 38 ± 6.5a,b 38 ± 5.9a,b
HS 14 ± 1.9 33 ± 8.3a 15 ± 1.8 14 ± 1.7 19 ± 3.2a 18 ± 2.5 17 ± 2.3 18 ± 2.6
AL (mmol/l)
LR 0.65 ± 0.2 1.30 ± 0.3a 2.28 ± 0.4a 3.57 ± 0.5a 3.48 ± 0.6a 4.08 ± 0.8a 4.60 ± 1.1a 4.90 ± 1.3a
HS 1.16 ± 0.2 1.76 ± 0.2a 2.67 ± 0.3a 3.55 ± 0.2a 4.02 ± 0.2a 4.11 ± 0.2a 4.10 ± 0.2a 4.20 ± 0.2a
HCO3 (mmol/l)
LR 23.0 ± 0.6 22.6 ± 0.8 21.1 ± 0.7a 21.1 ± 0.7a 20.0 ± 0.5a 18.7 ± 0.6a 17.6 ± 1.0a 17.4 ± 1.2a
HS 22.5 ± 0.6 21.8 ± 0.7 20.7 ± 0.5a 18.3 ± 0.7 18.6 ± 0.7a 18.3 ± 0.7a 18.1 ± 0.5a 17.6 ± 0.5a
Na (mmol/l)
LR 146.6 ± 0.1 146.7 ± 0.3 147.0 ± 0.5 146.7 ± 0.4b 147.6 ± 0.4b 146.7 ± 0.7b 145.3 ± 0.9b 146.1 ± 0.8b
HS 145.6 ± 0.7 145.9 ± 0.4 146.4 ± 0.7 157.1 ± 0.7a 155.8 ± 0.7a 156.5 ± 0.6a 155.9 ± 0.7a 155.9 ± 0.7a
Hb (g/dl)
LR 12.9 ± 0.4 13.5 ± 0.5 15.1 ± 0.6a 13.6 ± 0.3 14.1 ± 0.3a 14.4 ± 0.5a 15.3 ± 0.4a 15.6 ± 0.3a
HS 13.6 ± 0.4 14.2 ± 0.4 15.5 ± 0.5a 13.3 ± 0.6 14.8 ± 0.7 15.5 ± 0.7a 15.9 ± 0.7a 16.5 ± 0.7a
Bacterial infusion: intravenous infusion of 1.2 × 1010 cfu/kg of live Escherichia coli in 30 minutes in both groups. Fluid resuscitation: LR group 
received lactated Ringer's solution 32 ml/kg over 30 minutes, n = 7; HS group received 7.5% hypertonic saline solution 4 ml/kg over 5 minutes, n 
= 8. Follow up: 120 minutes without additional interventions. sDO2, systemic oxygen delivery; sVO2, systemic oxygen consumption; sO2ER, 
systemic oxygen extraction rate; Na, plasmatic sodium; AL, arterial lactate; HCO3, bicarbonate; Hb, hemoglobin. ap < 0.05 versus T0, both 
groups; bp < 0.05, LR versus HS.
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Effects of fluid replacement
Fluid infusion with a large volume of LR or a small volume of
HS promoted similar hemodynamic effects. Both fluid replace-
ment regimens were associated with transient increases in
cardiac output (Figure 1) and portal and renal blood flow (Fig-
ure 1), while increased systemic and mesenteric oxygen
extraction were ameliorated (Tables 1 and 2). Fluid infusion
did not change the progressive increases of pCO2 gradients
(D(v-a)pCO2, D(p-a)pCO2 and D(g-a)pCO2) in both groups
(Figure 3). By the end of the experimental protocol, no signifi-
cant differences between the groups could be detected for
systemic or regional hemodynamic variables (Figure 1), except
for an HS-induced significant and sustained improvement in
systemic and mesenteric oxygen extraction (Tables 1 and 2)
and, thus, a significant increase of mixed venous and portal
oxygen saturation (Figure 2). In spite of fluid infusion, arterial
and portal lactate levels showed a similar progressive increase
in both groups (Tables 1 and 2). A brief decrease toward
baseline hemoglobin levels was observed immediately after
fluid infusion in both groups (Table 1). Hypertonic saline infu-
sion induced a sustained increase in serum sodium levels
(Table 1).
Discussion
Using an intravenous injection of live E. coli, we reproduced
the hemodynamic and metabolic derangement observed in
non-resuscitated hypodynamic sepsis, characterized by imme-
diate and marked reduction of systemic and splanchnic blood
flow. A large volume of LR or a small volume of HS promoted
similar transient hemodynamic benefits, which were unable to
restore sepsis-induced perfusional deficits. However, a single
bolus of HS did promote sustained systemic and mesenteric
oxygen extraction reductions without deterioration of per-
fusional markers, such as lactate levels and pCO2 gradients.
Experimental data have shown a sepsis-induced impairment of
tissue oxygen extraction that contributes to an imbalance
between DO2 and VO2, possibly due to microcirculatory dys-
function [23] and cytopathic hypoxia [24]; thus, reductions in
oxygen extraction would be deleterious in septic settings.
However, Rivers and colleagues [9] have found that early goal-
directed therapy guided by restoration of central venous satu-
ration, which decreases sO2ER in septic patients, was associ-
ated with significant benefits related to outcome when it was
applied at an earlier stage of disease. In this context, since we
did not detect additional worsening in any systemic or regional
Table 2
Regional metabolic and oxygen-derived variables in both groups
Bacterial infusion Fluid resuscitation Follow up
T0 T30 T60 T90 T120 T150 T180 T210
mDO2 (ml/minute)
LR 103 ± 11 42 ± 4a 83 ± 10 86 ± 12 57 ± 8a 50 ± 6a 43 ± 6a 38 ± 5a
HS 86 ± 3 50 ± 3a 85 ± 13 69 ± 10 62 ± 9a 60 ± 9a 63 ± 9a 60 ± 8a
mVO2 (ml/minute)
LR 15.0 ± 2.3 11.3 ± 1.9 20.4 ± 2.5 19.7 ± 2.6 13.3 ± 2.7 15.9 ± 2.1 15.3 ± 2.1 10.5 ± 1.5
HS 14.8 ± 2.4 11.6 ± 1.5 13.1 ± 1.7 10.9 ± 1.6 11.5 ± 1.4 11.2 ± 1.2 12.6 ± 1.76 12.1 ± 2.1
mO2ER (%)
LR 11.2 ± 2.5 25.3 ± 5.1 22.8 ± 2.4a 24.7 ± 3.4a 32.64 ± 6.0a 38.0 ± 5.8a,b 39.9 ± 5.3a,b 36.5 ± 5.4a,b
HS 13.2 ± 1.7 22.8 ± 3.4a 18.8 ± 3.4 17.7 ± 2.7 20.3 ± 2.3a 19.8 ± 2.0 21.9 ± 2.2 18.5 ± 1.9
PgCO2 (mmHg)
LR 42.1 ± 1.7 51.4 ± 3.8a 60.2 ± 5.3a 72.2 ± 8.1a 75.2 ± 7.3a 77.0 ± 1.8a 84.8 ± 7.1a 89.7 ± 7.5a
HS 39.8 ± 1.6 45.1 ± 2.0a 53.5 ± 3.2a 56.0 ± 3.3a 62.8 ± 2.9a 68.8 ± 3.1a 75.5 ± 4.0a 80.6 ± 4.1a
PL (mmol/l)
LR 0.97 ± 0.3 1.73 ± 0.4a 2.48 ± 0.4a 3.70 ± 0.5a 3.65 ± 0.4a 4.14 ± 0.6a 5.21 ± 1.0a 4.70 ± 0.9a
HS 1.42 ± 0.2 1.98 ± 0.3a 2.81 ± 0.31a 4.24 ± 0.2a 4.88 ± 0.3a 4.52 ± 0.2a 4.61 ± 0.2a 4.52 ± 0.2a
Bacterial infusion: intravenous infusion of 1.2 × 1010 cfu/kg of live Escherichia coli in 30 minutes in both groups. Fluid resuscitation: LR group 
received lactated Ringer's solution 32 ml/kg over 30 minutes, n = 7; HS group received 7.5% hypertonic saline solution 4 ml/kg over 5 minutes, n 
= 8. Follow up: 120 minutes without additional interventions. mDO2, mesenteric oxygen delivery; mVO2, mesenteric oxygen consumption; mO2ER, 
mesenteric oxygen extraction rate; PgCO2, gastric mucosal pCO2; PL, portal vein lactate. Data are expressed as mean ± standard error. ap < 0.05 
versus T0, both groups; bp < 0.05, LR versus HS.
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tissue oxygen marker, we can assume that the reduction in
sO2ER and mO2ER, in this model, is a salutary effect of HS.
In stable septic patients, the use of HS/hydroxyethyl-starch
[25] and HS/dextran solution [16] produced transient
increases in cardiac output and DO2, similar to our findings.
However, they found no changes in oxygen extraction, which
could be explained by a previous hemodynamic resuscitation
with adequate volume and catecholamine infusion. Thus,
either there was no significant oxygen debt due to the already
elevated oxygen delivery levels at baseline or the global oxy-
gen measurements used were not able to detect regional
hypoxia [16]. In our model, HS and LR were the first fluid
replacements after septic insult, resembling the study by Riv-
ers and colleagues [9]. In spite of different amounts of volume
infused, the higher SvO2 and SpO2, as well as a trend toward
lower pCO2 gradients in HS animals, may be considered a
superiority of HS over LR resuscitation. We speculate that HS
reduced the oxygen extraction in this model through its capac-
ity to improve microcirculatory blood flow by capillary reopen-
ing, redistribution of regional blood flow and ameliorating the
mismatch between DO2 and VO2. However, we could not
exclude a possible metabolic effect of HS decreasing oxygen
demand as demonstrated experimentally [26].
The sustained high levels of lactate and pCO2 gradients after
HS infusion could have resulted from an obvious incomplete
hemodynamic resuscitation. Moreover, high lactate levels
could be explained by mechanisms other than anaerobic
metabolism [5,16]. In this scenario, the widening of pCO2 gra-
dients could have resulted from decreased blood flow with an
increase in tissue transit time and decreases in pulmonary
blood flow, or from an increase in aerobic production of CO2
without the required proportional increase of blood flow
[5,12,13,27].
Animal and clinical studies suggest that the microcirculatory
alterations are independent of systemic hemodynamic
changes. The perfusion of gut villi was markedly decreased in
septic rodents compared to hypovolemic controls with a simi-
lar degree of hypotension [28]. Norepinephrine infusion in
septic patients increased the mean arterial pressure and car-
diac output, whereas skin microvascular blood flow and gas-
tric mucosal pCO2 remained unchanged [29]. In accordance
with the above studies, comparing our septic model with con-
trolled hemorrhagic shock in dogs [13], we observed that
higher mean arterial pressure, cardiac output, and systemic
and regional oxygen delivery in septic animals resulted, para-
doxically, in higher D(g-a)pCO2 gradients than those observed
in animals subjected to hemorrhagic shock [13]. Additionally,
while in septic animals the increase in D(g-a)pCO2 was three-
fold higher than the increase observed in the D(p-a)pCO2 gra-
dient, in hemorrhagic animals it was only two-fold higher.
These phenomena reflect the more profound effect of hypop-
erfusion on the gut mucosal layer versus the mesenteric bed
as a whole, and highlight the worst derangement of sepsis-
induced gut perfusion, probably due to the association of
altered blood flow, microvascular dysfunction and tissue met-
abolic disturbances. We also observed that the D(p-a)pCO2
gradient accompanied the changes of portal blood flow while
the D(g-a)pCO2 gradient did not parallel either systemic or
regional blood flow trends, suggesting that microcirculatory
blood flow distribution within the gastrointestinal wall could
not be predicted from macrocirculatory regional or systemic
blood flow measurements. In fact, we and others have failed to
demonstrate a good correlation between the gastric mucosal-
arterial pCO2 gradient and hepatosplanchnic blood flow
[5,12-14,30].
Oi and colleagues [17] showed in a porcine endotoxin shock
model that a 7.5% saline/6% dextran-70 infusion improved
cardiac output, portal and intestinal mucosal blood flow and
ameliorated the intestinal-arterial pCO2 gradient compared to
isotonic (0.9%) saline/6% dextran-70. These benefits were
also accompanied by lower mortality [17]. Several reasons
could explained these divergent findings. First, we did not
associate dextran, a colloid whose antithrombotic, hemorheo-
logical and blood cell-endothelial cell interaction modulating
effects are well known [17]. Secondly, HS in the presence of
colloid provides plasma volume expansion for a longer period
Figure 2
Mixed venous (SvO2) and portal (SpO2) oxygen saturation (%, mean ± stan ard error of the mean) during the experiment l protocol
standard error of the mean) during the experimental protocol. LR group 
received lactated Ringer's solution 32 ml/kg over 30 minutes, n = 7; 
HS group received 7.5% hypertonic saline solution 4 ml/kg over 5 min-
utes, n = 8. *p < 0.05 versus T0, both groups; †p < 0.05 versus HS; 
‡LR, p < 0.05 versus T0. BI, bacterial infusion.
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of time [15]. Moreover, while we evaluated the same sodium
load in different volumes, they used the same volume with dif-
ferent sodium loads.
Both sepsis and fluid infusion may induce endothelial and red
blood cell edema, which reduces the capillary lumen, and
increases viscosity and hydraulic resistance, leading to an
early compromise of microcirculatory blood flow. The large
crystalloid volume required during initial resuscitation in septic
patients, about 6 to 10 liters, in the first hours [2,9], results in
hemodilution of plasma proteins and reduction of colloid
osmotic pressure. It leads to interstitial fluid accumulation,
which may worsen gas exchange, decrease myocardial com-
pliance, limits oxygen diffusion to the tissues, and contributes
to metabolic acidosis [2,31]. Moreover, a large crystalloid vol-
ume can itself result in fluid overload, where the lung and gut
are primarily affected, and is associated with primary and sec-
ondary intra-abdominal hypertension, decreased intestinal per-
fusion, prolonged mechanical ventilation, increased incidence
of multiple organ failure and death [32-34]. It should be noted
that we obtained similar hemodynamic benefits with a small
volume of HS (almost eight times smaller than in resuscitation
using LR), which could ultimately avoid the aforementioned
deleterious effects of fluid overload.
Figure 3
Venous-arterial pCO2 gradient (D(v-a)pCO2; mmHg, mean ± standard error of the mean (SEM)), portal-arterial pCO2 gradient (D(p-a)pCO2; mmHg, m an ± SEM) and gast ic mucosal rterial pCO2 gradi nt (D(g-a)pCO2; mmHg, mean ±  during the experimental protocol
mean ± SEM) and gastric mucosal-arterial pCO2 gradient (D(g-a)pCO2; mmHg, mean ± SEM) during the experimental protocol. LR group received 
lactated Ringer's solution 32 ml/kg over 30 minutes, n = 7; HS group received 7.5% hypertonic saline solution 4 ml/kg over 5 minutes, n = 8. *p < 
0.05 versus T0, both groups; # HS, p < 0.05 versus T0.
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Our animals were not fully resuscitated with both fluids regi-
mens, and this could be a possible explanation for the mainte-
nance of a comparable D(g-a)pCO2 in both HS and LR groups
throughout the experimental protocol. Furthermore, the
increase in hemoglobin levels after bacterial challenge and
transient decrease after fluid replacement suggests increased
microvascular permeability with extravascular redistribution of
the infused fluid and sustained hypovolemia. Splenocontrac-
tion during septic insult could also contribute to the observed
changes in hemoglobin levels during the experimental proto-
col. However, in a previous study, we observed the same
behavior of hemoglobin levels during the bacterial infusion and
fluid resuscitation in splenectomized dogs [5].
There are some limitations in our experimental model and pro-
tocol. Our model induced an immediate hemodynamic col-
lapse. This behavior is seldom observed in clinical sepsis,
although it may mimic some extreme conditions such as
meningococcemia, pneumococcal bacteremia in asplenic indi-
viduals and severe infections in the presence of profound
granulocytopenia [11]. Resuscitation tends to be an ongoing
process, while our study followed a strict protocol of fluid
replacement, with no additional interventions. The short obser-
vation time makes it impossible to analyze the later impact of
the fluid resuscitation regimens on the development of multiple
organ dysfunction and survival. However, our goal was to
address the acute impact of small volume resuscitation on sys-
temic and regional levels, thereby allowing us to detect the
long-lasting effects and safety of this intervention.
Conclusion
We conclude that the early large volume of LR and single small
bolus of HS promoted similar hemodynamic benefits in this
hypodynamic septic model. Nevertheless, the sustained
reductions in systemic and mesenteric oxygen extraction with-
out worsening other perfusional markers in HS animals sug-
gest that it may be a potential tool in the resuscitation of septic
patients. Further investigations are required, including longer
follow-up periods to appraise the real impact of this interven-
tion on the development of multiple organ dysfunction and sur-
vival.
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